Effects of electroacupuncture combined with paliperidone palmitate long-acting injection on withdrawal symptoms and neurotransmitters in methamphetamine addicts

被引:0
|
作者
Chen, Yu [1 ]
Wei, Wen-Jie [1 ]
Gong, Ji-Fen [1 ]
Qiao, Juan [1 ]
Wu, Chun-Xi [1 ]
Wang, Xiao-Jun [1 ]
Ding, Ying [1 ]
Chen, Hong-Yuan [1 ]
Lu, Hua-Xin [1 ]
Li, Ming-Chao [2 ]
Ji, Qiu-Ming [1 ]
机构
[1] Wuhan Wudong Hosp, Dept Psychiat, 46 Wudong St, Wuhan 430084, Peoples R China
[2] Wuhan Mental Hlth Ctr, Dept Psychiat, Wuhan, Peoples R China
关键词
Electroacupuncture treatment; methamphetamine; neurotransmitters; paliperidone palmitate long-acting injection; CLINICAL-PHARMACOLOGY; SCHIZOPHRENIA; NEUROTOXICITY;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
. Objective. To investigate the effects of electroacupuncture combined with paliperidone palmitate long-acting injection (PP-LAI) on withdrawal symptoms and neurotransmitters in methamphetamine (MA) addicts. Materials and methods. A total of 109 methamphetamine addicts, who were treated in the hospital from October 2021 to October 2022, were selected. According to the random number table, the patients were divided into the study group (n=54) and the control group (n=55), in which the control group was treated with PP-LAI and the study group was treated with electroacupuncture on the basis of the control group; the methamphetamine withdrawal symptom score scale was used to assess the therapeutic effect before treatment and within 12 months after treatment; the changes of brain neurotransmitters dopamine, gamma-aminobutyric acid, serotonin, acetylcholine values were compared between the two groups. Results .1) There was no statistical difference in MA withdrawal symptom scores between the two groups before treatment (p>0.05); 2) MA withdrawal symptom scores have a statistically significant difference between the study group and the control group after 3 and 6 months of treatment; 3) dopamine levels in the study group were significantly higher than those in the control group after 6 months of completion of treatment, and gamma-aminobutyric acid values and 5- serotonin values in the study group were significantly lower than those in the control group (p<0.05). Conclusions. Electroacupuncture combined with PP-LAI can partially improve the withdrawal symptoms and anxiety of methamphetamine addicts. This is a potential treatment for preventing relapse of withdrawal symptoms.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [1] Clinical Study of Paliperidone Palmitate Long-Acting Injection Combined With Electroacupuncture in the Treatment of Methamphetamine Addicts
    Chen, Yu
    Li, Mingchao
    Ji, Qiuming
    Su, Zou
    Yang, Ziyu
    Xu, Yin
    Chen, Qian
    Liao, Dan
    Zeng, Jihua
    Yang, Yuhong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Paliperidone palmitate long-acting injection in schizophrenic patients
    Suarez Gisbert, E.
    EUROPEAN PSYCHIATRY, 2020, 63 : S540 - S540
  • [3] Preparation, in vitro and in vivo Evaluation of Paliperidone Palmitate Long-acting Injection
    Wang, Dan
    Shi, Junfeng
    Zhang, Hui
    Zheng, Aiping
    Wang, Ting
    Chinese Journal of Pharmaceuticals, 2023, 54 (06) : 902 - 908
  • [4] Paliperidone palmitate long-acting injection in adolescents: report of two cases
    Fabrega Ribera, M.
    Garcia Chulbi, S.
    Sugranyes Ernest, G.
    Baeza Pertegaz, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S606 - S607
  • [5] Use of paliperidone palmitate long-acting injection in dual diagnosis patients
    De Cates, A.
    Sridharan, S.
    Ndebele, F.
    Kunar, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S321 - S322
  • [6] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [7] Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    Inoue, Yuichi
    Takaya, Atsuhiko
    ASIAN JOURNAL OF PSYCHIATRY, 2018, 35 : 28 - 28
  • [8] Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection
    Mesones-Peral, Jesus E.
    Gurillo-Munoz, Pedro
    Paz Sanchez-Sicilia, Mari
    Miller, Adam
    Grinant-Fernandez, Alejandra
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 33 - 37
  • [9] A case report of pregnancy and paliperidone palmitate 3-monthly long-acting injection
    de Azevedo Avelar, Rita
    Luengo Corbal, Antonio
    Heitor, Maria Joao
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2592 - 2594
  • [10] The impact of paliperidone palmitate long-acting injection on hospital admissions in a mental health setting
    Nikolic, Nikola
    Page, Natalie
    Akram, Adil
    Khan, Maha
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 95 - 102